Alexion Pharma (ALXN) Tops Q2 EPS by 2c; Increases FY11 Outlook
Tweet Send to a Friend
Alexion Pharma (NASDAQ: ALXN) reported Q2 EPS of $0.29, $0.02 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
